Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $100,047 - $123,374
-10,055 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $1,187 - $1,863
-121 Reduced 1.19%
10,055 $110,000
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $123,027 - $149,383
10,176 New
10,176 $138,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $161,870 - $220,829
-11,911 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $170,327 - $223,212
11,911 New
11,911 $223,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Hilltop Holdings Inc. Portfolio

Follow Hilltop Holdings Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.